![]() |
Photo from medinenet.com |
Meningococcal meningitis is a rare, but potentially fatal, bacterial infection. It causes inflammation of the membranes that shield the brain and spinal cord. Meningococcal illness, which includes meningitis and septicemia, affects roughly 1,000 persons in the United States each year (blood infection).
Without quick treatment, meningococcal meningitis can be fatal or cause significant injury; one in every five persons who receive the virus develops major consequences. According to the Centers for Disease Control and Prevention, even with antibiotics, 10 to 15% of those infected will die, and 1 in 5 of those who survive will have long-term disabilities such as hearing, brain damage, neurological disorders, and even limb loss.
Here’s all you need to know about meningococcal meningitis symptoms and how to prevent and treat it.
WHAT ARE THE SYMPTOMS OF MENINGOCOCCAL MENINGITIS
- General dissatisfaction
- High fever that appears unexpectedly
- Severe, on-going headache
- Stiffness in the neck
- Vomiting or nausea
- Discomfort when exposed to bright lighting
- Drowsiness or difficulties waking up
- Joint discomfort
- Confusion or other types of mental changes
- Soft area that is tense or bulging (in babies)
- cry that is high-pitched or moaning (in babies)
- Movements that are stiff, jerky, or floppy (in babies or toddlers)
- Irritability
- Rapid breathing
- Excessive drowsiness or lethargy
- Blotchy skin that turns pale or blue
- Shivering, as well as cold hands and feet
- Seizure
WHAT ARE THE CAUSES OF MENINGOCOCCAL MENINGITIS?
WHAT ARE THE TREATMENTS FOR MENINGOCOCCAL MENINGITIS?
- You are experiencing symptoms of meningococcal meningitis.
- Treatment has no effect on the symptoms.
- You believe you were exposed to meningococcal meningitis.
ARE VACCINES AVAILABLE FOR MENINGOCOCCAL MENINGITIS?
- Meningococcal conjugate vaccine (MCV4): Menactra, one of these vaccinations, is licensed for persons aged 9 months to 55. Menveo, on the other hand, is utilized in people aged 2 to 55.
- Meningococcal polysaccharide vaccine (MPSV4): This vaccine, which was licensed in the 1970s, protects against the majority of meningococcal diseases. This vaccine is intended for adults as young as 9 months old and as elderly as 55.
- Serogroup B Meningococcal B (MenB): There are two MenB vaccinations available. Trumenba (MenB-FHbp) and Bexsero (MenB-4C). Both are approved for usage in patients aged 10 to 24, however they can also be used in older adults.
- Individuals who believe they have been exposed to meningococcal meningitis
- College students who live in dorms
- Recruits for the U.S. military
- Travelers to places of the world where meningococcal illness is frequent, such as Africa, should be cautious.
- People who have a spleen that has been destroyed or who have terminal complement component deficiency, an immune system problem
- Lab workers who are frequently exposed to meningococcal germs
- Have a history of severe adverse reactions to earlier doses
- Have a serious allergy to any component of the vaccine
- Have you ever been diagnosed with Guillain-Barre Syndrome or acute disseminated encephalomyelitis?